Worth the Wait Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients. by Sharon Tregaskis Nothing but Time A father with metastatic kidney cancer embraces moments with his 3-year-old son while pondering how he’ll be remembered. by Adam P. Stern Survivor Profile The Gift of Music A self-taught musician takes what he has learned from his experience with kidney cancer to entertain, teach and inspire. by Jenny Song Survivor Profile The Jazz Evangelist Even through cancer treatment, jazz pianist and radio show host Billy Foster is ensuring that jazz is passed on to future generations. by Jenny Song Forward Look Keeping Hope Alive Q & A with author Amanda Bennett on her quest to understand the medical decisions made during her late husband's cancer treatment. by Yasmine Iqbal Cancer Talk Cancer Centers Cope With COVID-19 Surge Doctors at cancer centers in states with record COVID-19 hospitalization rates reflect on how lessons from early in the pandemic are helping them care for patients during the current surge. by Ashley P. Taylor Why Do African Americans Have Increased Breast Cancer Mortality? Socioeconomic factors and racism can lead to poorer health outcomes for Black Americans. Genetics may also be a factor behind increased mortality rates. by Marci A. Landsmann Liquid Biopsies May Ease Enrollment in Clinical Trials A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials. by Emma Yasinski What Is Tumor Mutational Burden? The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types. by Anna Azvolinsky More Posts